Featured Interviews

Xortx Therapeutics (CSE: XRX) (OTCQB: XRTXF)

Xortx CEO Dr. Allen Davidoff took time to update investors on the company’s accomplishments over the last several months. XRX just announced a partnership with Mount Sinai’s Icahn school of medicine for a US based COVID-19 clinical trial for acute kidney injury associated with the virus. […]

No Picture
News Feed

Citius Forms Scientific Advisory Board for the Planned Development of its Proprietary Treatment for Acute Respiratory Disease Associated with COVID-19

– Pulmonology opinion leaders in ARDS therapies will bring invaluable insight in Company’s clinical trial design CRANFORD, N.J., July 22, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“CITIUS”) (“Company”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing and […]

CEO Interviews

Victoria Gold Corp (TSX: VGCX)(OTC: VITFF) Interview Update with CEO John McConnell

WSA caught up with VIT to discuss progress since their previous interview from September 2019. The company has since uplisted to the TSX and reached commercial production on their Eagle Gold Mine in the Yukon, Canada. They have also completed a 23 million public offering and seen the stock nearly triple in the last 3 months. […]

News Feed

HAPPY CANADA DAY – VICTORIA GOLD DECLARES COMMERCIAL PRODUCTION AT THE EAGLE GOLD MINE, YUKON, CANADA

Whitehorse, YT / July 1, 2020 / Victoria Gold Corp. (TSX-VGCX) (“Victoria” or the “Company”) is pleased to provide an update regarding commercial production and Covid-19 protocols as production continues at the Eagle Gold Mine […]